After watching its rheumatoid arthritis med Actemra go up on in flames in COVID-19 trials, Swiss drugmaker Roche opted to sign an August antibody manufacturing pact with Regeneron. Now, seeking to get its manufacturing house in order, Roche is splashing the pot on a new global logistics hub in Canada.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,